Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Anxo Pharmaceutical CoROCO:6677 -3.82%62 Days Inventory is 169.07 as of Dec. 2025, which is 2% below its 10-year median of 172.22. GuruFocus rates ROCO:6677 with a GF Score™ of 62/100 and a GF Value™ of NT$30.25 (Possible Value Trap). The stock has 4 warning signs investors should review. Among 923 Drug Manufacturers companies, Anxo Pharmaceutical Co ranks worse than 54.17% on this metric.
The historical rank and industry rank for Anxo Pharmaceutical Co's Days Inventory or its related term are showing as below:
ROCO:6677'
s Days Inventory Range Over the Past 10 Years
Min: 146.69 Med: 172.22 Max: 187.49
Current: 174.78
During the past 13 years, Anxo Pharmaceutical Co's highest Days Inventory was 187.49. The lowest was 146.69. And the median was 172.22.
ROCO:6677's Days Inventory is ranked worse than 54.17% of 923
companies
in the Drug Manufacturers industry
Industry Median: 164.38
vs ROCO:6677: 174.78
Anxo Pharmaceutical Co's Days Inventory
declined
from Dec. 2024 (170.92) to Dec. 2025 (169.07).
Inventory Turnover measures how fast the company turns over its inventory within a year.
Anxo Pharmaceutical Co's Inventory Turnover for the
six
months ended in Dec. 2025 was 1.08.
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Anxo Pharmaceutical Co's Inventory-to-Revenue for the
six
months ended in Dec. 2025 was 0.59.
Anxo Pharmaceutical Co (ROCO:6677) Days Inventory Explanation
Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:
1. Inventory Turnover measures how fast the company turns over its inventory within a year.
Anxo Pharmaceutical Co's Inventory Turnover for the
six
months ended in Dec. 2025 is calculated as
2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Anxo Pharmaceutical Co's Inventory to Revenue for the
six
months ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.
Anxo Pharmaceutical Co Days Inventory Related Terms
Anxo Pharmaceutical Co Days Inventory Historical Data
* Premium members only.
The historical data trend for Anxo Pharmaceutical Co's Days Inventory can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - Specialty & Generic subindustry, Anxo Pharmaceutical Co's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Anxo Pharmaceutical Co Days Inventory vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Anxo Pharmaceutical Co's Days Inventory distribution charts can be found below:
* The bar in red indicates where Anxo Pharmaceutical Co's Days Inventory falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Anxo Pharmaceutical Co (ROCO:6677) has a Days Inventory of 169.07 as of Dec. 2025. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Anxo Pharmaceutical Co and its competitors. This is near median its historical median of 172.22. Over the past decade, Anxo Pharmaceutical Co's Days Inventory has ranged from 146.69 to 187.49. According to the industry distribution chart, Anxo Pharmaceutical Co ranks #500 out of 923 companies in the Drug Manufacturers industry, placing it in the top 54.2%.
Is Anxo Pharmaceutical Co's Days Inventory too high?
Anxo Pharmaceutical Co's current Days Inventory of 169.07 is near median its 10-year median of 172.22. Over the past 10 years, this metric has ranged from a low of 146.69 to a high of 187.49. The Drug Manufacturers industry median Days Inventory is 164.38. Anxo Pharmaceutical Co's value of 169.07 is 2.9% above this industry median. Based on the distribution chart, Anxo Pharmaceutical Co ranks #500 out of 923 companies in the Drug Manufacturers industry, which is below the industry midpoint. Overall, Anxo Pharmaceutical Co has a GF Score™ of 62/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Anxo Pharmaceutical Co's Days Inventory compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Anxo Pharmaceutical Co ranks #500 out of 923 companies for Days Inventory. This places Anxo Pharmaceutical Co in the lower half of its industry. The industry median Days Inventory is 164.38. Anxo Pharmaceutical Co's value of 169.07 is 2.9% above this benchmark. Historically, Anxo Pharmaceutical Co's own Days Inventory has ranged from 146.69 to 187.49 over the past decade. While the company's 10-year median is 172.22 vs. the industry median of 164.38, Anxo Pharmaceutical Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Inventory for a Drug Manufacturers company?
The median Days Inventory among Drug Manufacturers companies is 164.38, based on 923 companies in the industry. Companies in the top quartile (top 25%) have a Days Inventory significantly above this median, while those in the bottom quartile fall well below. However, Days Inventory should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Anxo Pharmaceutical Co's current Days Inventory of 169.07 is 2.9% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Inventory mean?
A high Days Inventory can signal that a stock is expensive relative to its fundamentals. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Anxo Pharmaceutical Co and its competitors. For the Drug Manufacturers industry, the median Days Inventory is 164.38 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Anxo Pharmaceutical Co's current Days Inventory is 169.07, which is near median its own 10-year median of 172.22. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Anxo Pharmaceutical Co stock overvalued right now?
Based on GuruFocus' analysis, Anxo Pharmaceutical Co (ROCO:6677) is currently considered Possible Value Trap. The stock's GF Value™ is NT$30.25, compared to a current price of NT$16.35 — trading 46% below its estimated fair value. The current Days Inventory is 169.07, which is near median its 10-year median of 172.22 and 2.9% above the Drug Manufacturers industry median of 164.38. Anxo Pharmaceutical Co's overall GF Score™ is 62/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Inventory calculated?
Days Inventory is calculated from a company's financial statements. For Anxo Pharmaceutical Co (ROCO:6677), the current Days Inventory is 169.07 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Anxo Pharmaceutical Co (ROCO:6677) Overvalued in 2026?
Based on GuruFocus' analysis, Anxo Pharmaceutical Co stock appears to be undervalued.
The current stock price of NT$16.35 is trading 46% below its estimated GF Value™ of NT$30.25.
GuruFocus considers Anxo Pharmaceutical Co to be Possible Value Trap.
Key valuation signals for ROCO:6677:
Days Inventory: 169.07 (near median its 10-year median of 172.22)
GF Value™: NT$30.25 vs. price of NT$16.35 (46% below fair value)
Industry Position: 2.9% above the Drug Manufacturers median (#500 of 923)
No single metric tells the full story. See the ROCO:6677 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Anxo Pharmaceutical Co Ltd is a drug manufacturer. The company is engaged in developing drugs which include prescription medication and consumer healthcare medication. The products of the company include cardiovascular system medication, central nervous system medication, diabetes medication, infectious medicine, and dermatology medication.
62GF Score
Get the complete analysis for ROCO:6677
Days Inventory is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ROCO:6677 has been successfully added to your 
